As an alternative to liver transplantation, numerous researchers have been
working toward the goal of development of a fully functional artificial liv
er. In recent years, artificial liver support systems have been advocated a
s interim treatments for patients awaiting hepatocyte replacement therapy o
r liver transplantation; so-called "bridging" treatments. It is recognized
that an effective artificial liver system requires: (1) a viable and highly
functional hepatocyte cell line, (2) a suitable bioreactor environment and
peripheral control systems, and (3) an effective extracorporeal circulator
y system to incorporate an artificial liver system. Conventional systems ha
ve, however, suffered from various drawbacks, including incompatibility of
cell cultures derived from non-human cells, insufficient cell proliferation
, rapid deterioration of cellular function due to an impoverished cellular
environment, and lack of system scalability. A newly established artificial
liver system overcomes many of these problems and demonstrates a long-term
capacity to maintain multiple liver-specific functions, such as protein sy
nthesis, enzyme activity, and drug metabolism, both quantitatively and qual
itatively. The present review provides an overview of the concepts underpin
ning artificial liver systems, the performance of presently available syste
ms and the practical applications of available systems and those in develop
ment.